Behavioral Management of Phosphorus in Hemodialysis Patients

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 23, 2018

Primary Completion Date

May 1, 2018

Study Completion Date

May 1, 2018

Conditions
Cardiovascular Disease (CKD)Hyperphosphatemia
Interventions
BEHAVIORAL

Education (Edu)

This intervention will take place during weeks 1-4 at the dialysis center. Each week, study staff will present participants with a brief educational video on: phosphorus binder adherence (week 1), meeting dietary protein needs (week 2), restricting dietary sources of phosphorus (week 3), and eliminating phosphorus-based food additives (week 4). These videos will be loaded onto tablet (Personal Computers) PCs so that participants can easily view them during regular dialysis treatment.

BEHAVIORAL

SM intervention

During the first 12 weeks of the intervention, a study dietitian will review the participants' records, and provide individualized feedback via a password-protected NYULMC email address. Feedback will be provided twice per week during weeks 1-4, once per week during weeks 5-8, and once every two weeks during weeks 9-12. The email messages will focus on both the importance of self-monitoring and the behavioral targets of the intervention. Feedback will use standardized language rather than specific dietary examples to avoid providing individualized counseling to participants (which is not the purpose of the SM intervention).

BEHAVIORAL

Social Cognitive Therapy (SCT)

This intervention will be delivered remotely online using the same tablet PCs provided for the SM intervention component of this treatment condition. The behavioral training program will focus on building a sense of self-efficacy with emphasis on mastery experiences that will include emphasizing past successes; setting incremental, easily achievable goals; self-monitoring to stay on track; identifying modifiable barriers to healthy behavior; positive feedback in goal achievement; and developing participant expertise in both the regimen and in problem solving around barriers to adherence.

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT02940743 - Behavioral Management of Phosphorus in Hemodialysis Patients | Biotech Hunter | Biotech Hunter